vs
STANDARD BIOTOOLS INC.（LAB）与UNION BANKSHARES INC（UNB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是UNION BANKSHARES INC的1.4倍（$19.6M vs $14.1M），UNION BANKSHARES INC同比增速更快（6.3% vs -11.5%），UNION BANKSHARES INC自由现金流更多（$16.0M vs $-23.1M），过去两年UNION BANKSHARES INC的营收复合增速更高（10.2% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
大西洋联合银行股份是一家银行控股公司，总部位于弗吉尼亚州里士满，是区域银行大西洋联合银行的母公司。该公司在弗吉尼亚州、马里兰州和北卡罗来纳州共运营129家分行，是总部设于弗吉尼亚州的规模最大的银行，位列美国大型银行名单之中。
LAB vs UNB — 直观对比
营收规模更大
LAB
是对方的1.4倍
$14.1M
营收增速更快
UNB
高出17.8%
-11.5%
自由现金流更多
UNB
多$39.1M
$-23.1M
两年增速更快
UNB
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $14.1M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | 6.3% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABUNB
| Q4 25 | — | $14.1M | ||
| Q3 25 | $19.6M | $14.5M | ||
| Q2 25 | $21.8M | $13.2M | ||
| Q1 25 | $40.8M | $12.7M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | $22.1M | $11.0M | ||
| Q2 24 | $22.5M | $12.2M | ||
| Q1 24 | $45.5M | $11.6M |
净利润LABUNB
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $3.4M | ||
| Q2 25 | $-33.5M | $2.4M | ||
| Q1 25 | $-26.0M | $2.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $1.3M | ||
| Q2 24 | $-45.7M | $2.0M | ||
| Q1 24 | $-32.2M | $2.4M |
毛利率LABUNB
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABUNB
| Q4 25 | — | — | ||
| Q3 25 | -168.5% | — | ||
| Q2 25 | -118.1% | — | ||
| Q1 25 | -80.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -120.9% | — | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -132.2% | — |
净利率LABUNB
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | 23.7% | ||
| Q2 25 | -153.7% | 18.1% | ||
| Q1 25 | -63.8% | 19.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 12.0% | ||
| Q2 24 | -203.3% | 16.5% | ||
| Q1 24 | -70.6% | 20.9% |
每股收益（稀释后）LABUNB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.09 | $0.75 | ||
| Q2 25 | $-0.09 | $0.52 | ||
| Q1 25 | $-0.07 | $0.55 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | $-0.07 | $0.29 | ||
| Q2 24 | $-0.12 | $0.45 | ||
| Q1 24 | $-0.27 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $80.9M |
| 总资产 | $539.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABUNB
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
总债务LABUNB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABUNB
| Q4 25 | — | $80.9M | ||
| Q3 25 | $399.7M | $77.7M | ||
| Q2 25 | $424.5M | $71.3M | ||
| Q1 25 | $454.6M | $70.1M | ||
| Q4 24 | — | $66.5M | ||
| Q3 24 | $489.3M | $72.3M | ||
| Q2 24 | $510.3M | $64.0M | ||
| Q1 24 | $577.3M | $63.8M |
总资产LABUNB
| Q4 25 | — | $1.6B | ||
| Q3 25 | $539.6M | $1.6B | ||
| Q2 25 | $557.0M | $1.5B | ||
| Q1 25 | $579.6M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $681.5M | $1.5B | ||
| Q2 24 | $708.7M | $1.4B | ||
| Q1 24 | $777.7M | $1.4B |
负债/权益比LABUNB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $17.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $16.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 113.6% |
| 资本支出强度资本支出/营收 | 4.5% | 8.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $29.1M |
8季度趋势，按日历期对齐
经营现金流LABUNB
| Q4 25 | — | $17.2M | ||
| Q3 25 | $-22.2M | $9.7M | ||
| Q2 25 | $-20.7M | $288.0K | ||
| Q1 25 | $-30.3M | $4.1M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | $-27.9M | $1.3M | ||
| Q2 24 | $-39.0M | $3.3M | ||
| Q1 24 | $-62.5M | $1.9M |
自由现金流LABUNB
| Q4 25 | — | $16.0M | ||
| Q3 25 | $-23.1M | $9.6M | ||
| Q2 25 | $-22.6M | $-381.0K | ||
| Q1 25 | $-35.3M | $3.9M | ||
| Q4 24 | — | $11.1M | ||
| Q3 24 | $-30.1M | $1.1M | ||
| Q2 24 | $-41.0M | $2.9M | ||
| Q1 24 | $-63.3M | $1.5M |
自由现金流率LABUNB
| Q4 25 | — | 113.6% | ||
| Q3 25 | -118.1% | 65.9% | ||
| Q2 25 | -103.6% | -2.9% | ||
| Q1 25 | -86.6% | 30.8% | ||
| Q4 24 | — | 83.8% | ||
| Q3 24 | -136.4% | 9.7% | ||
| Q2 24 | -182.2% | 23.8% | ||
| Q1 24 | -138.9% | 12.8% |
资本支出强度LABUNB
| Q4 25 | — | 8.9% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 5.1% | ||
| Q1 25 | 12.4% | 1.1% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | 10.2% | 1.9% | ||
| Q2 24 | 8.6% | 2.7% | ||
| Q1 24 | 1.7% | 3.3% |
现金转化率LABUNB
| Q4 25 | — | — | ||
| Q3 25 | — | 2.83× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 1.62× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.97× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
UNB
暂无分部数据
